| Pharmaceutical active ingredients: |
| Pirenzepine Hydrochloride |
| Available forms, composition and doses of Ulcuforton: |
| N / A |
| Ulcuforton medical category: |
| Human:Antimuscarinics antispasmodics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A02BX03 - Pirenzepine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ulcin | Pirenzepine Hydrochloride | Istituto Bioterapico Nazionale |
| Ulcopir | Pirenzepine Hydrochloride | Aesculapius Farmaceutici |
| Ulcoprotect | Pirenzepine Hydrochloride | Sandoz |
| Ulcosafe | Pirenzepine Hydrochloride | BASF |
| Ulcosyntex | Pirenzepine Hydrochloride | Francia Farmaceutici Industria Farmaco Biologica |
| Ulgescum | Pirenzepine Hydrochloride | Dolorgiet |
| Ulpir | Pirenzepine Hydrochloride | Istituto Biochimico Pavese Pharma |
| Duo Vizerul | Pirenzepine Hydrochloride; Ranitidine Hydrochloride | Disprofarma |
| Arelix | Piretanide | Sanofi-Aventis; Bipharma |
| Arelix Mite | Piretanide | Sanofi-Aventis |